Rexulti 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FTWM7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,510
Award facts
- Contract value 100% obligated
- $14,510.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,510.26 to DMS Pharmaceutical Group Inc. for the supply of Rexulti 1 mg tablets (30-count packages) with an ultimate completion date of September 25, 2025. The contract represents a firm fixed-price delivery order with no set-aside designation, and performance will take place in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected as the prime contractor for this award.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency, valued at $499,999,999 and valid through November 2026. Under this master contract vehicle, the DLA issues firm fixed-price delivery orders for pharmaceutical products supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, consistently securing contracts for a diverse portfolio of branded and generic prescription drugs, biologics, and medical consumables that serve Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FTWM7?
SPE2DB25FTWM7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FTWM7 worth?
The government has obligated $14,510 on SPE2DB25FTWM7.
Is contract SPE2DB25FTWM7 an order under another contract?
Yes. SPE2DB25FTWM7 is a delivery order under SPE2DB20D6037, an indefinite delivery contract.
Was contract SPE2DB25FTWM7 competed?
The extent of competition for SPE2DB25FTWM7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award